The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase.

alpha-D-glucose is a weak inhibitor (Ki = 1.7 mM) of glycogen phosphorylase (GP) and acts as physiological regulator of hepatic glycogen metabolism; it binds to GP at the catalytic site and stabilizes the inactive T state of the enzyme promoting the action of protein phosphatase 1 and stimulating gl...

Full description

Bibliographic Details
Main Authors: Oikonomakos, N, Kontou, M, Zographos, SE, Tsitoura, H, Johnson, L, Watson, K, Mitchell, E, Fleet, G, Son, J, Bichard, C
Format: Conference item
Published: 1994